Global and United States Direct-to-consumer Genetic Health Sequencing Market Report & Forecast 2022-2028

Table of Contents

1 Study Coverage

• 1.1 Direct-to-consumer Genetic Health Sequencing Revenue in Direct-to-consumer Genetic Health Sequencing Business (2017-2022) & (US$ Million) Introduction
• 1.2 Global Direct-to-consumer Genetic Health Sequencing Outlook 2017 VS 2022 VS 2028
  • 1.2.1 Global Direct-to-consumer Genetic Health Sequencing Market Size for the Year 2017-2028
  • 1.2.2 Global Direct-to-consumer Genetic Health Sequencing Market Size for the Year 2017-2028
• 1.3 Direct-to-consumer Genetic Health Sequencing Market Size, United States VS Global, 2017 VS 2022 VS 2028
  • 1.3.1 The Market Share of United States Direct-to-consumer Genetic Health Sequencing in Global, 2017 VS 2022 VS 2028
  • 1.3.2 The Growth Rate of Direct-to-consumer Genetic Health Sequencing Market Size, United States VS Global, 2017 VS 2022 VS 2028
• 1.4 Direct-to-consumer Genetic Health Sequencing Market Dynamics
  • 1.4.1 Direct-to-consumer Genetic Health Sequencing Industry Trends
  • 1.4.2 Direct-to-consumer Genetic Health Sequencing Market Drivers
  • 1.4.3 Direct-to-consumer Genetic Health Sequencing Market Challenges
  • 1.4.4 Direct-to-consumer Genetic Health Sequencing Market Restraints
• 1.5 Study Objectives
• 1.6 Years Considered

2 Direct-to-consumer Genetic Health Sequencing by Type

• 2.1 Direct-to-consumer Genetic Health Sequencing Market Segment by Type
  • 2.1.1 Diagnostic Screening
  • 2.1.2 PGD Relationship Testing
• 2.2 Global Direct-to-consumer Genetic Health Sequencing Market Size by Type (2017, 2022 & 2028)
• 2.3 Global Direct-to-consumer Genetic Health Sequencing Market Size by Type (2017-2028)
• 2.4 United States Direct-to-consumer Genetic Health Sequencing Market Size by Type (2017, 2022 & 2028)
• 2.5 United States Direct-to-consumer Genetic Health Sequencing Market Size by Type (2017-2028)

3 Direct-to-consumer Genetic Health Sequencing by Application

• 3.1 Direct-to-consumer Genetic Health Sequencing Market Segment by Application
  • 3.1.1 Online
  • 3.1.2 Offline
• 3.2 Global Direct-to-consumer Genetic Health Sequencing Market Size by Application (2017, 2022 & 2028)
• 3.3 Global Direct-to-consumer Genetic Health Sequencing Market Size by Application (2017-2028)
• 3.4 United States Direct-to-consumer Genetic Health Sequencing Market Size by Application (2017, 2022 & 2028)
• 3.5 United States Direct-to-consumer Genetic Health Sequencing Market Size by Application (2017-2028)

4 Global Direct-to-consumer Genetic Health Sequencing Competitor Landscape by Company

• 4.1 Global Direct-to-consumer Genetic Health Sequencing Market Size by Company
  • 4.1.1 Top Global Direct-to-consumer Genetic Health Sequencing Companies Ranked by Revenue (2021)
  • 4.1.2 Global Direct-to-consumer Genetic Health Sequencing Revenue by Player (2017-2022)
• 4.2 Global Direct-to-consumer Genetic Health Sequencing Concentration Ratio (CR)
  • 4.2.1 Direct-to-consumer Genetic Health Sequencing Market Concentration Ratio (CR) (2017-2022)
  • 4.2.2 Global Top 5 and Top 10 Largest Companies of Direct-to-consumer Genetic Health Sequencing in 2021
  • 4.2.3 Global Direct-to-consumer Genetic Health Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 4.3 Global Direct-to-consumer Genetic Health Sequencing Headquarters, Revenue in Direct-to-consumer Genetic Health Sequencing Business (2017-2022) & (US$ Million) Type
  • 4.3.1 Global Direct-to-consumer Genetic Health Sequencing Headquarters and Area Served
  • 4.3.2 Global Direct-to-consumer Genetic Health Sequencing Companies Revenue in Direct-to-consumer Genetic Health Sequencing Business (2017-2022) & (US$ Million) Type
  • 4.3.3 Date of International Companies Enter into Direct-to-consumer Genetic Health Sequencing Market
• 4.4 Companies Mergers & Acquisitions, Expansion Plans
• 4.5 United States Direct-to-consumer Genetic Health Sequencing Market Size by Company
  • 4.5.1 Top Direct-to-consumer Genetic Health Sequencing Players in United States, Ranked by Revenue (2021)
  • 4.5.2 United States Direct-to-consumer Genetic Health Sequencing Revenue by Players (2020, 2021 & 2022)

5 Global Direct-to-consumer Genetic Health Sequencing Market Size by Region

• 5.1 Global Direct-to-consumer Genetic Health Sequencing Market Size by Region: 2017 VS 2022 VS 2028
• 5.2 Global Direct-to-consumer Genetic Health Sequencing Market Size by Region (2017-2028)
  • 5.2.1 Global Direct-to-consumer Genetic Health Sequencing Market Size by Region: 2017-2022
  • 5.2.2 Global Direct-to-consumer Genetic Health Sequencing Market Size by Region (2023-2028)

6 Segment in Region Level & Country Level

• 6.1 North America
  • 6.1.1 North America Direct-to-consumer Genetic Health Sequencing Market Size YoY Growth 2017-2028
  • 6.1.2 North America Direct-to-consumer Genetic Health Sequencing Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.1.3 United States
  • 6.1.4 Canada
• 6.2 Asia-Pacific
  • 6.2.1 Asia-Pacific Direct-to-consumer Genetic Health Sequencing Market Size YoY Growth 2017-2028
  • 6.2.2 Asia-Pacific Direct-to-consumer Genetic Health Sequencing Market Facts & Figures by Region (2017, 2022 & 2028)
  • 6.2.3 China
  • 6.2.4 Japan
  • 6.2.5 South Korea
  • 6.2.6 India
  • 6.2.7 Australia
  • 6.2.8 China Taiwan
  • 6.2.9 Indonesia
  • 6.2.10 Thailand
  • 6.2.11 Malaysia
• 6.3 Europe
  • 6.3.1 Europe Direct-to-consumer Genetic Health Sequencing Market Size YoY Growth 2017-2028
  • 6.3.2 Europe Direct-to-consumer Genetic Health Sequencing Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.3.3 Germany
  • 6.3.4 France
  • 6.3.5 U.K.
  • 6.3.6 Italy
  • 6.3.7 Russia
• 6.4 Latin America
  • 6.4.1 Latin America Direct-to-consumer Genetic Health Sequencing Market Size YoY Growth 2017-2028
  • 6.4.2 Latin America Direct-to-consumer Genetic Health Sequencing Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.4.3 Mexico
  • 6.4.4 Brazil
  • 6.4.5 Argentina
• 6.5 Middle East and Africa
  • 6.5.1 Middle East and Africa Direct-to-consumer Genetic Health Sequencing Market Size YoY Growth 2017-2028
  • 6.5.2 Middle East and Africa Direct-to-consumer Genetic Health Sequencing Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.5.3 Turkey
  • 6.5.4 Saudi Arabia
  • 6.5.5 UAE

7 Company Profiles

• 7.1 23andMe
  • 7.1.1 23andMe Company Details
  • 7.1.2 23andMe Business Overview
  • 7.1.3 23andMe Direct-to-consumer Genetic Health Sequencing Introduction
  • 7.1.4 23andMe Revenue in Direct-to-consumer Genetic Health Sequencing Business (2017-2022)
  • 7.1.5 23andMe Recent Development
• 7.2 MyHeritage
  • 7.2.1 MyHeritage Company Details
  • 7.2.2 MyHeritage Business Overview
  • 7.2.3 MyHeritage Direct-to-consumer Genetic Health Sequencing Introduction
  • 7.2.4 MyHeritage Revenue in Direct-to-consumer Genetic Health Sequencing Business (2017-2022)
  • 7.2.5 MyHeritage Recent Development
• 7.3 LabCorp
  • 7.3.1 LabCorp Company Details
  • 7.3.2 LabCorp Business Overview
  • 7.3.3 LabCorp Direct-to-consumer Genetic Health Sequencing Introduction
  • 7.3.4 LabCorp Revenue in Direct-to-consumer Genetic Health Sequencing Business (2017-2022)
  • 7.3.5 LabCorp Recent Development
• 7.4 Myriad Genetics
  • 7.4.1 Myriad Genetics Company Details
  • 7.4.2 Myriad Genetics Business Overview
  • 7.4.3 Myriad Genetics Direct-to-consumer Genetic Health Sequencing Introduction
  • 7.4.4 Myriad Genetics Revenue in Direct-to-consumer Genetic Health Sequencing Business (2017-2022)
  • 7.4.5 Myriad Genetics Recent Development
• 7.5 Ancestry.com
  • 7.5.1 Ancestry.com Company Details
  • 7.5.2 Ancestry.com Business Overview
  • 7.5.3 Ancestry.com Direct-to-consumer Genetic Health Sequencing Introduction
  • 7.5.4 Ancestry.com Revenue in Direct-to-consumer Genetic Health Sequencing Business (2017-2022)
  • 7.5.5 Ancestry.com Recent Development
• 7.6 Quest Diagnostics
  • 7.6.1 Quest Diagnostics Company Details
  • 7.6.2 Quest Diagnostics Business Overview
  • 7.6.3 Quest Diagnostics Direct-to-consumer Genetic Health Sequencing Introduction
  • 7.6.4 Quest Diagnostics Revenue in Direct-to-consumer Genetic Health Sequencing Business (2017-2022)
  • 7.6.5 Quest Diagnostics Recent Development
• 7.7 Gene By Gene
  • 7.7.1 Gene By Gene Company Details
  • 7.7.2 Gene By Gene Business Overview
  • 7.7.3 Gene By Gene Direct-to-consumer Genetic Health Sequencing Introduction
  • 7.7.4 Gene By Gene Revenue in Direct-to-consumer Genetic Health Sequencing Business (2017-2022)
  • 7.7.5 Gene By Gene Recent Development
• 7.8 DNA Diagnostics Center
  • 7.8.1 DNA Diagnostics Center Company Details
  • 7.8.2 DNA Diagnostics Center Business Overview
  • 7.8.3 DNA Diagnostics Center Direct-to-consumer Genetic Health Sequencing Introduction
  • 7.8.4 DNA Diagnostics Center Revenue in Direct-to-consumer Genetic Health Sequencing Business (2017-2022)
  • 7.8.5 DNA Diagnostics Center Recent Development
• 7.9 Invitae
  • 7.9.1 Invitae Company Details
  • 7.9.2 Invitae Business Overview
  • 7.9.3 Invitae Direct-to-consumer Genetic Health Sequencing Introduction
  • 7.9.4 Invitae Revenue in Direct-to-consumer Genetic Health Sequencing Business (2017-2022)
  • 7.9.5 Invitae Recent Development
• 7.10 IntelliGenetics
  • 7.10.1 IntelliGenetics Company Details
  • 7.10.2 IntelliGenetics Business Overview
  • 7.10.3 IntelliGenetics Direct-to-consumer Genetic Health Sequencing Introduction
  • 7.10.4 IntelliGenetics Revenue in Direct-to-consumer Genetic Health Sequencing Business (2017-2022)
  • 7.10.5 IntelliGenetics Recent Development
• 7.11 Ambry Genetics
  • 7.11.1 Ambry Genetics Company Details
  • 7.11.2 Ambry Genetics Business Overview
  • 7.11.3 Ambry Genetics Direct-to-consumer Genetic Health Sequencing Introduction
  • 7.11.4 Ambry Genetics Revenue in Direct-to-consumer Genetic Health Sequencing Business (2017-2022)
  • 7.11.5 Ambry Genetics Recent Development
• 7.12 Living DNA
  • 7.12.1 Living DNA Company Details
  • 7.12.2 Living DNA Business Overview
  • 7.12.3 Living DNA Direct-to-consumer Genetic Health Sequencing Introduction
  • 7.12.4 Living DNA Revenue in Direct-to-consumer Genetic Health Sequencing Business (2017-2022)
  • 7.12.5 Living DNA Recent Development
• 7.13 EasyDNA
  • 7.13.1 EasyDNA Company Details
  • 7.13.2 EasyDNA Business Overview
  • 7.13.3 EasyDNA Direct-to-consumer Genetic Health Sequencing Introduction
  • 7.13.4 EasyDNA Revenue in Direct-to-consumer Genetic Health Sequencing Business (2017-2022)
  • 7.13.5 EasyDNA Recent Development
• 7.14 Pathway Genomics
  • 7.14.1 Pathway Genomics Company Details
  • 7.14.2 Pathway Genomics Business Overview
  • 7.14.3 Pathway Genomics Direct-to-consumer Genetic Health Sequencing Introduction
  • 7.14.4 Pathway Genomics Revenue in Direct-to-consumer Genetic Health Sequencing Business (2017-2022)
  • 7.14.5 Pathway Genomics Recent Development
• 7.15 Centrillion Technology
  • 7.15.1 Centrillion Technology Company Details
  • 7.15.2 Centrillion Technology Business Overview
  • 7.15.3 Centrillion Technology Direct-to-consumer Genetic Health Sequencing Introduction
  • 7.15.4 Centrillion Technology Revenue in Direct-to-consumer Genetic Health Sequencing Business (2017-2022)
  • 7.15.5 Centrillion Technology Recent Development
• 7.16 Xcode
  • 7.16.1 Xcode Company Details
  • 7.16.2 Xcode Business Overview
  • 7.16.3 Xcode Direct-to-consumer Genetic Health Sequencing Introduction
  • 7.16.4 Xcode Revenue in Direct-to-consumer Genetic Health Sequencing Business (2017-2022)
  • 7.16.5 Xcode Recent Development
• 7.17 Color Genomics
  • 7.17.1 Color Genomics Company Details
  • 7.17.2 Color Genomics Business Overview
  • 7.17.3 Color Genomics Direct-to-consumer Genetic Health Sequencing Introduction
  • 7.17.4 Color Genomics Revenue in Direct-to-consumer Genetic Health Sequencing Business (2017-2022)
  • 7.17.5 Color Genomics Recent Development
• 7.18 Anglia DNA Services
  • 7.18.1 Anglia DNA Services Company Details
  • 7.18.2 Anglia DNA Services Business Overview
  • 7.18.3 Anglia DNA Services Direct-to-consumer Genetic Health Sequencing Introduction
  • 7.18.4 Anglia DNA Services Revenue in Direct-to-consumer Genetic Health Sequencing Business (2017-2022)
  • 7.18.5 Anglia DNA Services Recent Development
• 7.19 African Ancestry
  • 7.19.1 African Ancestry Company Details
  • 7.19.2 African Ancestry Business Overview
  • 7.19.3 African Ancestry Direct-to-consumer Genetic Health Sequencing Introduction
  • 7.19.4 African Ancestry Revenue in Direct-to-consumer Genetic Health Sequencing Business (2017-2022)
  • 7.19.5 African Ancestry Recent Development
• 7.20 Canadian DNA Services
  • 7.20.1 Canadian DNA Services Company Details
  • 7.20.2 Canadian DNA Services Business Overview
  • 7.20.3 Canadian DNA Services Direct-to-consumer Genetic Health Sequencing Introduction
  • 7.20.4 Canadian DNA Services Revenue in Direct-to-consumer Genetic Health Sequencing Business (2017-2022)
  • 7.20.5 Canadian DNA Services Recent Development
• 7.21 DNA Family Check
  • 7.21.1 DNA Family Check Company Details
  • 7.21.2 DNA Family Check Business Overview
  • 7.21.3 DNA Family Check Direct-to-consumer Genetic Health Sequencing Introduction
  • 7.21.4 DNA Family Check Revenue in Direct-to-consumer Genetic Health Sequencing Business (2017-2022)
  • 7.21.5 DNA Family Check Recent Development
• 7.22 Alpha Biolaboratories
  • 7.22.1 Alpha Biolaboratories Company Details
  • 7.22.2 Alpha Biolaboratories Business Overview
  • 7.22.3 Alpha Biolaboratories Direct-to-consumer Genetic Health Sequencing Introduction
  • 7.22.4 Alpha Biolaboratories Revenue in Direct-to-consumer Genetic Health Sequencing Business (2017-2022)
  • 7.22.5 Alpha Biolaboratories Recent Development
• 7.23 Test Me DNA
  • 7.23.1 Test Me DNA Company Details
  • 7.23.2 Test Me DNA Business Overview
  • 7.23.3 Test Me DNA Direct-to-consumer Genetic Health Sequencing Introduction
  • 7.23.4 Test Me DNA Revenue in Direct-to-consumer Genetic Health Sequencing Business (2017-2022)
  • 7.23.5 Test Me DNA Recent Development
• 7.24 23 Mofang
  • 7.24.1 23 Mofang Company Details
  • 7.24.2 23 Mofang Business Overview
  • 7.24.3 23 Mofang Direct-to-consumer Genetic Health Sequencing Introduction
  • 7.24.4 23 Mofang Revenue in Direct-to-consumer Genetic Health Sequencing Business (2017-2022)
  • 7.24.5 23 Mofang Recent Development
• 7.25 Genetic Health
  • 7.25.1 Genetic Health Company Details
  • 7.25.2 Genetic Health Business Overview
  • 7.25.3 Genetic Health Direct-to-consumer Genetic Health Sequencing Introduction
  • 7.25.4 Genetic Health Revenue in Direct-to-consumer Genetic Health Sequencing Business (2017-2022)
  • 7.25.5 Genetic Health Recent Development
• 7.26 DNA Services of America
  • 7.26.1 DNA Services of America Company Details
  • 7.26.2 DNA Services of America Business Overview
  • 7.26.3 DNA Services of America Direct-to-consumer Genetic Health Sequencing Introduction
  • 7.26.4 DNA Services of America Revenue in Direct-to-consumer Genetic Health Sequencing Business (2017-2022)
  • 7.26.5 DNA Services of America Recent Development
• 7.27 Shuwen Health Sciences
  • 7.27.1 Shuwen Health Sciences Company Details
  • 7.27.2 Shuwen Health Sciences Business Overview
  • 7.27.3 Shuwen Health Sciences Direct-to-consumer Genetic Health Sequencing Introduction
  • 7.27.4 Shuwen Health Sciences Revenue in Direct-to-consumer Genetic Health Sequencing Business (2017-2022)
  • 7.27.5 Shuwen Health Sciences Recent Development
• 7.28 Mapmygenome
  • 7.28.1 Mapmygenome Company Details
  • 7.28.2 Mapmygenome Business Overview
  • 7.28.3 Mapmygenome Direct-to-consumer Genetic Health Sequencing Introduction
  • 7.28.4 Mapmygenome Revenue in Direct-to-consumer Genetic Health Sequencing Business (2017-2022)
  • 7.28.5 Mapmygenome Recent Development
• 7.29 Full Genomes
  • 7.29.1 Full Genomes Company Details
  • 7.29.2 Full Genomes Business Overview
  • 7.29.3 Full Genomes Direct-to-consumer Genetic Health Sequencing Introduction
  • 7.29.4 Full Genomes Revenue in Direct-to-consumer Genetic Health Sequencing Business (2017-2022)
  • 7.29.5 Full Genomes Recent Development

8 Research Findings and Conclusion

9 Appendix

• 9.1 Research Methodology
  • 9.1.1 Methodology/Research Approach
  • 9.1.2 Data Source
• 9.2 Author Details